Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

7.940
-0.010-0.13%
Volume:82.61M
Turnover:658.85M
Market Cap:91.48B
PE:19.68
High:8.070
Open:7.820
Low:7.820
Close:7.950
52wk High:11.454
52wk Low:4.152
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:0.82
T/O Rate:0.72%
Dividend:0.25
Dividend Rate:3.10%
EPS(LYR):0.404
ROE:10.83%
ROA:5.65%
PB:2.51
PE(LYR):19.68
PS:3.22

Loading ...

CSPC Pharmaceutical Group Ltd. Buys Back 3,000,000 Shares at Average Price of HK$8.86 Each for Approximately HK$26.59 Million

Reuters
·
Oct 17

CSPC Pharmaceutical Group Stock Sheds 4.1% in Hong Kong

Dow Jones
·
Oct 17

CSPC PHARMA (01093) Purchases a Total of 4.496 Million Shares Under Restricted Stock Award Scheme

Stock News
·
Oct 16

CSPC Pharmaceutical Group Ltd. Buys Back 4,496,000 Shares at Average Price of HK$9.27 for Approximately HK$41.68 Million

Reuters
·
Oct 16

CSPC Pharmaceutical Group Stock Advances 3.5% in Hong Kong, Outperforms Competitors

Dow Jones
·
Oct 15

CSPC PHARMA (01093) Purchases 6 Million Shares Under Restricted Share Award Plan

Stock News
·
Oct 14

CSPC Pharmaceutical Group Ltd. Buys Back 6,000,000 Shares at Average Price of HK$8.84 for Approximately HK$53 Million

Reuters
·
Oct 14

CSPC Pharmaceutical Group Stock Sheds 7.1% in Hong Kong, Underperforms Competitors

Dow Jones
·
Oct 14

Hong Kong Stock Market Preview | Spot Silver Prices Surge Dramatically, BEIGENE's Sotorasib Receives Breakthrough Therapy Designation

Stock News
·
Oct 14

CSPC PHARMA (01093): Trustee Purchases 3 Million Company Shares Under Share Award Scheme

Stock News
·
Oct 13

CSPC Pharmaceutical Group Ltd. Buys Back 3,000,000 Shares at Average Price of HK$9.33 Each for Total Consideration of Approximately HK$27,975,000

Reuters
·
Oct 13

CSPC PHARMA (01093): New Drug Application for Idaglutide Alpha Injection Accepted by National Medical Products Administration

Stock News
·
Oct 13

CSPC PHARMA (01093) Receives Drug Registration Approval for Tacrolimus Extended-Release Capsules

Stock News
·
Oct 13

CSPC Pharmaceutical Group Receives Regulatory Approval in China for Tacrolimus Extended-Release Capsules

Reuters
·
Oct 13

CSPC Pharmaceutical - Tacrolimus Extended-Release Capsules Obtain Drug Registration Approval

THOMSON REUTERS
·
Oct 13

CSPC Pharmaceutical Group's New Drug Application for Efmedaglutide Alfa Injection Accepted by China's NMPA for Obesity Treatment

Reuters
·
Oct 13

CSPC Pharmaceutical - Announces Nmpa Acceptance of New Drug Application

THOMSON REUTERS
·
Oct 13

CSPC Pharmaceutical - New Drug Application for Efmedaglutide Alfa Injection Accepted by Nmpa China

THOMSON REUTERS
·
Oct 13

CSPC Pharmaceutical Group (SEHK:1093): Evaluating Valuation After a Strong Year for Shares

Simply Wall St.
·
Oct 13

CSPC Pharmaceutical Group Stock Climbs 1.4% in Hong Kong, Outperforms Competitors

Dow Jones
·
Oct 10